SEBI Reg. Investment Advisor

Download App
Help Center Subscribe
Money Works 4 Me Logo MoneyWorks4Me
Talk to Advisor
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

Dhansa Labs Ltd (DHANSA)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: DHANSA Pesticides & Agrochemicals | Small Cap | Dhansa Labs Share Price

BSE Share Price
Not Listed

Dhansa Labs Ltd (DHANSA)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: DHANSA Pesticides & Agrochemicals | Small Cap | Dhansa Labs Share Price

BSE Share Price
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹68 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
₹2.1
TTM Sales
₹142 Cr.
Book Value per Share
₹27.3
P/E Ratio
11.95
Lower than its 5-year historical median
Industry PE
30.4
Price to Book (P/B)
0.93
Lower than its 5-year historical median
Price to Sales (P/S)
0.48
Lower than its 5-year historical median
EV/EBITDA
8.50
Lower than its 5-year historical median
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
11.01%
Underperforms industry median
Return on Capital Employed (ROCE)
11.43%
Underperforms industry median
Return on Assets (ROA)
4.72%
Operating Profit Margin
7.3%
Net Profit Margin
3.64%
Gross Profit Margin
6.5%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
8.96%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
5.95%
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
-38.08%
Asset Quality
Promoter Holding
70.15%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹47 Cr.
Equity
₹26.9 Cr.
Face Value
₹10
All Time Low / High
- / -

Dhansa Labs stock performance

Key Ratios
mw4me loader

Check Before You Invest

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is Dhansa Labs Ltd a good quality company?
Dhansa Labs Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

View More

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

View More
How does Dhansa Labs Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Dhansa Labs Ltd vs industry peers?
Dhansa Labs Ltd revenue CAGR is 0.00%, compared to the industry median CAGR of 8.45%, indicating slower growth and losing its market share.
Q.1 Promoter shareholding and pledge status of Dhansa Labs Ltd?
Promoters hold 70.15% of the Dhansa Labs Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Dhansa Labs Ltd over the last decade?
Over the last 1 year(s), the stock has delivered a CAGR of -40% based on the current price.
View More

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Dhansa Labs Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation ⓘ

Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % ⓘ28.7%25.4%25.4%21.4%11.4%-
Value Creation
Index ⓘ		1.10.80.80.5-0.2-

Growth Parameters ⓘ
Sales ⓘ81.784.6105120131142
Sales YoY Gr.-3.5%23.9%14.9%9%-
Adj EPS ⓘ211.92.94.21.92.1
YoY Gr.--90.8%52.3%42.9%-55.2%-
BVPS (₹) ⓘ-16.110.74.911.226.427.3
Adj Net
Profit ⓘ		10.33.45.27.94.76
Cash Flow from Ops. ⓘ2.75.610.1-13.2-34.5-
Debt/CF from Ops. ⓘ123.21.4-2.3-1.2-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘNANA15.8%9%
Adj EPS ⓘNANA-0.9%-55.2%
BVPSⓘNANA35%134.9%
Share Price - - - -34.4%

Key Financial Parameters ⓘ

Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity % ⓘ		-13161.327.3318.77.9
Op. Profit
Mgn % ⓘ		11.912.27.57.57.36.6
Net Profit
Mgn % ⓘ		12.64.156.53.64.1
Debt to
Equity ⓘ		-4.211.61.40.60.2
Working Cap
Days ⓘ		09690114185237
Cash Conv.
Cycle ⓘ		001341121145

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'21Mar'22Mar'23Mar'24Mar'25
Sales81.7484.60104.82120.47131.27
Operating Expenses ⓘ + 71.9974.2596.97111.39121.65
Manufacturing Costs0.510.250.530.480.30
Material Costs66.3568.9090.62106.65117
Employee Cost 1.681.702.211.381.36
Other Costs ⓘ 3.443.403.602.883
Operating Profit ⓘ 9.7510.357.859.089.62
Operating Profit Margin (%) 11.9%12.2%7.5%7.5%7.3%
Other Income ⓘ + 0.680.512.771.591.92
Exceptional Items ⓘ 00-0.06-0.300
Interest ⓘ 4.113.062.092.422.95
Depreciation ⓘ 3.222.972.962.522.54
Profit Before Tax ⓘ 3.094.835.505.436.04
Tax ⓘ -7.251.260.26-2.291.26
Profit After Tax 10.343.575.247.724.78
PAT Margin (%) 12.7%4.2%5.0%6.4%3.6%
Adjusted EPS (₹)21.12.03.04.11.9
Dividend Payout Ratio (%)0%0%0%0%0%

Valuation of Dhansa Labs - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + -7.8619.0719.1431.5176.35
Share Capital ⓘ 4.8917.7517.7518.6924.95
Reserves ⓘ -12.761.321.3912.8251.40
Debt +29.6014.3113.2016.3210.75
Long Term Debt29.6014.3113.2016.3210.75
Short Term Debt00000
Minority Interest00000
Trade Payables16.1914.8716.2114.806.63
Others Liabilities ⓘ -0.541.715.0414.1032.06
Total Liabilities ⓘ 37.3949.9653.5976.74125.79

Fixed Assets

Net Fixed Assets ⓘ +15.8525.0925.2223.9823.12
Gross Block40.8753.0856.1757.1058.35
Accumulated Depreciation25.0227.9930.9633.1335.24
CWIP ⓘ 0.95003.8415.66
Investments ⓘ 000.600.780
Inventories8.7310.7517.1220.5729.91
Trade Receivables6.978.523.5718.6940.43
Cash Equivalents 0.510.290.410.381.76
Others Assets ⓘ 4.385.316.688.5014.90
Total Assets ⓘ 37.3949.9653.5976.74125.79

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity ⓘ + 2.745.6110.05-13.15-34.48
PBT ⓘ 3.094.835.505.436.04
Adjustment ⓘ 7.245.984.794.175.18
Changes in Working Capital ⓘ -8.12-5.97-0.85-21.5-44.57
Tax Paid ⓘ 0.530.770.61-1.25-1.13
Cash Flow From Investing Activity ⓘ + -1.17-0.75-3.69-5.28-13.50
Capex -1.21-0.76-3.09-5.11-13.52
Net Investments 00-0.60-0.18-0.13
Others ⓘ 0.040.010.010.010.15
Cash Flow From Financing Activity ⓘ + -1.49-5.08-6.2318.3948.34
Net Proceeds from Shares ⓘ 0004.6542.55
Net Proceeds from Borrowing ⓘ -0.73-2.44-1.573.12-5.57
Interest Paid ⓘ -4.10-3.05-1.84-1.78-2.91
Dividend Paid ⓘ 00000
Others ⓘ 3.330.41-2.8212.4014.27
Net Cash Flow ⓘ 0.09-0.220.13-0.030.36

Financial Ratio

PARTICULARSMar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)N/A63.8237.8252.0811.01
ROCE (%)N/A25.3825.3721.411.43
Asset Turnover Ratio2.191.942.021.851.3
PAT to CFO Conversion(x)0.261.571.92-1.7-7.21
Working Capital Days
Receivable Days31.1033.4021.1033.7082.20
Inventory Days394248.5057.1070.20
Payable Days89.1082.3062.6053.1033.40

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Dhansa Labs Ltd FAQs

The current trading price of Dhansa Labs on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Dhansa Labs stood at ₹68.47 Cr

The latest P/E ratio of Dhansa Labs as of 31-Dec-1969 is 11.95.

The latest P/B ratio of Dhansa Labs as of 31-Dec-1969 is 0.93.

The 52-week high of Dhansa Labs is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Dhansa Labs is ₹142 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Dhansa Labs Ltd is a average quality company.

The key valuation ratios of Dhansa Labs Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Dhansa Labs Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Dhansa Labs Ltd

Ambey Laboratories Limited was originally incorporated as a private limited company namely ‘Ambey Laboratories Private Limited’ under the Companies Act, 1956 vide certificate of incorporation dated March 20, 1985 issued by Registrar of Companies, NCT of Delhi. Further, the company was converted into a Public Limited Company in pursuance of a special resolution passed by the members of the company at the Extra Ordinary General Meeting held on November 15, 2014. A fresh Certificate of Incorporation consequent to conversion was issued on December 30, 2014 by the Registrar of Companies, NCT of Delhi and consequently the name of the Company was changed from ‘Ambey Laboratories Private Limited’ to ‘Ambey Laboratories Limited’.

The company is engaged in the business of manufacturing of agrochemical products for the protecting of crops. The company manufactures and supplies ‘2,4-D base chemicals’ with an emphasis on quality and strict compliance with Environmental, Health, and Safety (EHS) regulations, within the chemical industry. The company has Programmable Logic Controller (PLC) and Supervisory Control along with Quality Assurance Department which ensures testing through HPLC, GC, UV etc. at every stage of production at its manufacturing facility installed, integrated and operating at 5 Acres Facility in the region of Behror, Rajasthan, India for manufacturing of ‘2, 4-D base chemicals’.

The company’s manufacturing Facility has been certified with ISO 9001:2015 from Quality Research Organization and ISO 14001:2015 from United Accreditation Foundation, a member of International Accreditation forum to maintain highest quality, environmental and safety practices. The company has obtained certificate of compliance from RoHS Directive (2015/863/EC) European Parliament and commission decision (2005/618/EC) on the restriction of use of certain Hazardous Substance [Lead (Pb), Mercury (Hg), Cadmium (Cd), Hexavalent Chromium (Cr6+), Polybrominated Biphenyls (PBBs) and Polybrominated Diphenyl, Bis (2-Ethylhexyl) phthalate (DEHP), Benzyl butyl phthalate (BBP), Dibutyl phthalate (DBP), Diisobutyl phthalate (DIBP)] ethers (PBDEs) in Electrical and Electrical Equipments.

The company works within an interconnected network alongside Aromatic Rasayan and OFB Tech. All the transactions are performed on arms- length basis and the company enters into transactions both in the capacity of suppliers and customers, it procures raw materials from these partners and delivers finalized products for their sale. This dynamic relationship streamlines the supply chain, promotes mutual support, and enhances the efficiency of operations for all involved parties.

Business area of the company

The company primarily engaged in the business of manufacturing and distribution of agro and home hygiene products.

Products of the company

Agro-chemical products 

  • 2,4-D Amine Salt 
  • 2,4-D Acid Tech (98% min)
  • 2,4-D Ethyl Ester Tech (95% min)
  • 2,4-D 2-Ethylhexyl Ester Tech (96% min)
  • 2,4-D Sodium Salt (95% min)
  • Hexaconazole (5% min)

Home hygiene products

  • Black phenyle
  • White floor cleaner
  • Toilet cleaner
  • Surface & floor cleaner
  • Power cleaner
  • Glass cleaner
  • Moth repellent balls
  • Hand wash
  • Bathroom cleaner
  • Hand sanitizer

History and milestones

  • 1985: The company was incorporated as a Private Limited Company under the name ‘Ambey Laboratories Private Limited’.
  • 2014: The company was converted into Public Limited Company under the name ‘Ambey Laboratories Limited’.


You have 3 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: